Cambrex to Invest $16.5 Million in New R&D Facility in Minneapolis, Minnesota and Expansion in Charles City, Iowa
EAST RUTHERFORD, N.J., Oct. 27, 2022 /PRNewswire/ -- Cambrex today announced it is investing in a new, 21,000-square-foot research and development facility in Minneapolis, Minnesota, expanding its capacity for small molecule development and manufacturing. Strategically located near the Minneapolis–St. Paul Airport, the new facility will specialize in analytical and chemical development for...
Tsinghua SIGS Virtual Open Day 2023 | Where your future starts
Attending an Open Day is a great opportunity to find out about the postgraduate programs we offer. Watch information sessions delivered by our faculties and get a deeper insight into our excellent programs. We are for you to provide all the information you want, including how we can help build your career path, what the curriculum is like, what...
Gerresheimer and Merck Transform Primary Packaging into Digital Twins
DÜSSELDORF, Germany, Oct. 27, 2022 /PRNewswire/ -- Gerresheimer AG, a leading provider of healthcare solutions and drug delivery systems for pharma, biotech and cosmetics and Merck, Darmstadt, a leading science and technology company, jointly developed a digital twin solution to further ensure traceability and trust in crucial steps along the pharmaceutical supply chain. The proof of concept aims to transform...
Antengene to Host Research and Development Day on November 15th and 17th, 2022
Virtual English Session:Tuesday, November 15 at 8:30 AM – 12:00 PM Eastern TimeNovember 15 at 9:30 PM – November 16 at 1:00 AM Beijing Time Hybrid Mandarin Session in Shanghai:Thursday, November 17 at 1:30 PM – 5:30 PM Beijing Time SHANGHAI and HONG KONG, Oct. 27, 2022 /PRNewswire/ --...
Aged care sector turns to financial wellbeing tools to attract staff: Wagestream
SYDNEY, Oct. 27 2022 /PRNewswire/ -- Financial wellbeing fintech Wagestream has signed with Southern Cross Care, Vacenti, and CareChoice in quick succession this month, as Australian aged care and caring businesses increasingly turn to innovative tech-based financial wellbeing tools to address the current talent and hiring crises. Josh Vernon, Wagestream Australia CEO Across the board, Southern Cross Care Queensland, Vacenti, and...
Telix Recognised as Company of the Year at AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2022
MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is today pleased to announce that it has been awarded Australian Company of the Year in the 2022 AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards, held today at the AusBiotech 2022 national conference in Perth. The...
DR. FAIKA KHAN CEO OF CITY DOCTOR PVT. LTD. AND MR ALI J HASHMAT CEO OF CURE PARTNERS PVT. LTD. ANNOUNCEMENT OF FULL ACQUISITION OF “THE MEDICAL LABORATORY PVT....
NEW YORK, Oct. 27, 2022 /PRNewswire/ -- Dr Faika Khan CEO of CITY DOCTOR PVT. LTD. and Mr. Ali J Hashmat of CURE PARTNERS PVT. LTD. announced 100% acquisition of "The Medical laboratory Pvt. Ltd." Doing Businesses as (DBA) "ZEENAT LAB", one of the most renowned lab with a history of over 50 plus years serving the community. ZEENAT...
Cali Biosciences Announces Publications of Phase IIa Results of Long-Acting Ropivacaine (CPL-01)
CPL-01, for Non-Opioid Treatment of Post-Operative Pain, Garners Publication of Clinical Data in Abdominoplasty and Presentation of Preclinical Data in Bony and Soft-Tissue Models Supporting Pharmacokinetics and Safety SAN DIEGO, Oct. 27, 2022 /PRNewswire/ -- Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali Biosciences"), a biopharmaceutical company focused on the research and development of innovative drugs, announced two major...
Forsea Attracts USD5.2M to Expand Cultivated Seafood, Without Harming Sea Life
Start-up pioneers organoid technology to make nature identical, cultured eel meat at cost parity REHOVOT, Israel, Oct. 27, 2022 /PRNewswire/ -- Forsea Foods, Ltd., a FoodTech start-up, is the first company to use organoid technology for culturing seafood products. With a goal of redressing the destruction of marine life due to overfishing, Forsea embarked on a mission to cultivate...
SUCCESSFUL PASSING OF EU QP AUDIT ON TOT BIOPHARM’S COMMERCIAL PRODUCTION BASE FOR MONOCLONAL ANTIBODY DRUG SUBSTANCES AND ANTIBODY DRUG CONJUGATES
SUZHOU,China, Oct. 27, 2022 /PRNewswire/ -- TOT BIOPHARM International Company Limited (TOT BIOPHARM, Stock code: 1875.HK) has recently received a GMP compliance inspection report approved by a Qualified Person ("QP") in the European Union ("EU") in respect of the manufacturing facilities and associated quality systems of the Group's commercial production base for its self-developed HER2-targeted antibody drug conjugate ("ADC") candidate, TAA013. Pursuant...
